Animal models relevant to schizophrenia and autism: Validity and limitations

Behavior Genetics

Volumn 37, Issue 1, 2007, Pages 61-78

  Tordjman, Sylvie ^a,b   Drapier, Dominique ^c   Bonnot, Olivier ^d   Graignic, Rozenn ^e   Fortes, Sylvia ^e   Cohen, David ^d   Millet, Bruno ^c   Laurent, Claudine ^f   Roubertoux, Pierre L ^e  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e CNRS   (France)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Animal models; Autism; Behavioral similarity; Brain; Genetics; Neurobiological similarity; Psychiatry; Schizophrenia

Indexed keywords

AUTISM; BEHAVIOR DISORDER; COGNITIVE DEFECT; DISEASE MODEL; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; NEUROBIOLOGY; NONHUMAN; REVIEW; SCHIZOPHRENIA; SOCIAL ISOLATION; SOCIOPATHY; STEREOTYPY;

ANIMALS; AUTISTIC DISORDER; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HUMANS; MICE; RATS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

ANIMALIA; RATTUS;

EID: 33846459373     PISSN: 00018244     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10519-006-9120-5     Document Type: Review

References (161)

1. Abraini JH, Ansseau M, Fechtali T (1993) Pressure-induced disorders in neurotransmission and spontaneous behavior in rats: an animal model of psychosis. Biol Psychiatry 34:622-629
2. Alaghband-Rad J, McKenna K, Gordon CT (1995) Childhood onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry 34:1275-1283
3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th edn. Text revision). American Psychiatric Association, Washington, DC
4. Andres C (2002) Molecular genetics and animal models in autistic disorder. Brain Res Bull 57(1):109-119
5. Asarnow JR, Tompson MC, Goldstein MJ (1994) Childhood-onset schizophrenia: a followup study. Schizophr Bull 20(4):599-617
6. Bachevalier J (1996) Brief report: medial temporal lobe and autism: a putative animal model in primates. J Autism Dev Disord 26(2):217-220
7. Bailer J, Brauer W, Rey ER (1996) Premorbid adjustment as predictor of outcome in schizophrenia results of a prospective study. Acta Psychiatr Scand 93(5):368-377
8. Bailey A, Luthert P, Dean A (1998) A clinicopathological study of autism. Brain 121:889-905
9. Baum KM, Walker EF (1995) Childhood behavioral precursors of adult symptom dimensions in schizophrenia. Schizophr Res 16:111-120
10. Bauman ML, Kemper TL (1985) Histoanatomic observations in the brain in early infantile autism. Neurology 35:866-874
11. Bauman ML, Le May M, Bauman RA, Rosenberger PB (1985) Computerized tomographic (CT) observations of the posterior fossa in early infantile autism (abstract). Neurology 35(1 Suppl):247S
12. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000) Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9:195-202
13. Bender L, Faetra G (1972) The relationship between childhood and adult schizophrenia. In: Kaplan AR (ed) Genetic factors in schizophrenia. Charles C. Thomas Publisher, Springfield III, pp 28-64
14. Berger P, Watson S, Akil H, Barchas JD (1981) Clinical studies on the role of endorphins in schizophrenia. Mod Probl Pharmacopsychiatr 17:226-235
15. Bleuler E (1911) Dementia Praecox oder Gruppe der Schizophrenien. Handbuch der Psychiatrie, Leipzig, Aschaffenburg
16. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181-188
17. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343
18. Brambilla F, Facchinetti F, Petraglia F, Vanzulli L, Genazzani AR (1984) Secretion pattern of endogenous opioids in chronic schizophrenia. Am J Psychiatry 141:1183-1188
19. Campbell M, Anderson LT, Small AM, Locascio JJ, Lynch NS, Choroco MC (1990) Naltrexone in autistic children: a double-blind and placebo-controlled study. Psychopharmacol Bull 26:130-135
20. Cantor S, Evans J, Pearce J, Pezzot-Pearce T (1982) Childhood schizophrenia: present but not accounted for. Am J Psychiatry 139:758-762
21. Carpenter WT, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578-583
22. Caston J, Yon E, Mellier D, Godfrey HP, Delhaye-Bouchaud N, Mariani J (1998) An animal model of autism: behavioural studies in the GS guinea-pig. Eur J Neurosci 10(8):2677-2684
23. Chamberlain RS, Herman BH (1990) A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism. Biol Psychiatry 28:773-793
24. Chisaka O, Musci TS, Capecchi MR (1992) Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox 1.6. Nature 355:516-520
25. Christison GW, Atwater GE, Dunn LA, Kilts CD (1988) Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biol Psychiatry 23:746-749
26. Chua SE, Murray RM (1996) The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Ann Med 28:547-555
27. Collins JS, Schroer RJ, Bird J, Michaelis RC (2003) The HOXA1 A218G polymorphism and autism: lack of association in white and black patients from the South Carolina Autism Project. J Autism Dev Disord 33:343-348
28. Conciatori M, Stodgell CJ, Hyman SL, O'bara M, Militerni R, Bravaccio C, Trillo S, Montecchi F, Schneider C, Melmed R, Elia M, Crawford L, Spence SJ, Muscarella L, Guarnieri V, D'agruma L, Quattrone A, Zelante L, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Rodier PM, Persico AM (2004) Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry 55:413-419
29. Courchesne E, Saitoh O, Yeung CR, Press GA, Lincoln AJ, Haas RH, Schreibman L (1994) Abnormalities of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am J Roentgenol 162:123-130
30. Courchesne E, Yeung-Courchesne R, Press GA, Hesslink JR, Jernigan TL (1987) Hypoplasia of cerebellar vermal lobules VI & VII in autism. N Engl J Med 318:1349-1354
31. Crawley JN (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. MRDD Res Rev 10:248-258
32. Devlin B, Bennett P, Cook EH, Dawson G, Gonen D, Grigorenko EL, Mcmahon W, Pauls D, Smith M, Spence MA, Schellenberg GD (2002) No evidence for linkage of liability to autism to HOXA1 in a sample from the CPEA network. Am J Med Genet 114:667-672
33. Dihoff RE, Hetznecker W, Brosvic GM, Carpenter LN, et al (1993) Ordinal measurement of autistic behavior: a preliminary report. Bull Psychonom Soc 31:287-290
34. Dunn LA, Atwater GE, Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology (Berl) 112:315-323
35. Ellenbroek BA, Artz MT, Cools AR (1991) The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196:103-108
36. Ellenbroek BA, Geyer MA, Cools AR (1995) The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci 15:7604-7611
37. Ellenbroek BA, Willemen AP, Cools AR (1989) Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys. Neuropsychopharmacology 2:191-199
38. Engelmann M, Landgraf R (1994) Microdialysis administration of vaso-pressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55:145-149
39. Feldon J, Weiner I (1991) The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biol Psychiatry 29:635-646
40. Ferguson JN, Aldag JM, Insel TR, Young LJ (2001) Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 21:8278-8285
41. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT (2000) Social amnesia in mice lacking the oxytocin gene. Nat Genet 25:284-287
42. Filipek PA, Richelme C, Kennedy DN, Rademacher J, Pitcher DA, Zidel SY, Caviness VS (1992) Morphometric analysis of the brain in developmental language disorders and autism. Ann Neurol 32:475
43. Fisch GS (2005) Invited comment. Syndromes and epistemology I: autistic spectrum disorders. Am J Med. Genet 135A:117-119
44. Fone KC, Nutt DJ (2005) Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol 1:87-93
45. Freedman R, Waldo M, Bickford-Wimer P, Nagamoto H (1991) Elementary neuronal dysfunctions in schizophrenia. Schizophr Res 4:233-243
46. Frescka E, Davis KL (1991) The opioid model in psychiatric research. In: Nemeroff CB (ed) Neuropeptides and psychiatric disorders. American Psychiatric Press, Washington, DC, pp 169-191
47. Friedlander K (1946). Psychoanalytic orientation in child guidance work in Great Britain. Psychoanal Study Child 2:343-357
48. Gaffney GR, Kuperman S, Tsai LT, Minchin S, Hassanein KM (1987) Mid-sagittal magnetic resonance imaging of autism. Br J Psychiatry 151:831-833
49. Gallagher L, Hawi Z, Kearney G, Fitzgerald M, Gill M (2004) No association between allelic variants of HOXA1/HOXB1 and autism. Am J Med Genet 124B:64-67
50. Garber HJ, Ritvo E, Chui LC, Griswold VJ, Kashanian A, Oldendorf WH (1989) A magnetic resonance imaging study of autism: normal fourth ventricle size and absence of pathology. Am J Psychiatry 146:532-534
51. Geyer MA, Markou A (2002) Animal models of psychiatric disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins, New York, pp 445-455
52. Gray JA (1998) Integrating schizophrenia. Schizophr Bull 24:249-266
53. Green L, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50:609-613
54. Guieu R, Samuelian JC, Coulouvrat H (1994) Objective evaluation of pain perception in patients with schizophrenia. Br J Psychiatry 164:253-255
55. Guimera J, Casas C, Pucharcos C, Solans A, Domenech A, Planas M, Asley J, Lovett M, Estivill X, Pritchard MA (1996) A human homologue of Drosophila minibrain (MBN) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 9:1305-1310
56. Harlow HF, McKinney WT (1971) Non-human primates and psychoses. J Autism Child Schiz 1:368-375
57. Herman BH, Panksepp J (1978) Effects of morphine and naloxone on separation distress and approach attachment: evidence for opiate medication of social affect. Pharmacol Biochem Behav 9:213-220
58. Holtum JR, Minshew NJ, Sanders RS, Phillips NE (1992) Magnetic resonance imaging of the posterior fossa in autism. Biol Psychiatry 32:1091-1101
59. Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:295-298
60. Houpt KA, McDonell SM (1993) Equine stereotypies. Comp Contin Educ Pract Vet 15:1265-1272
61. Ingram JL, Peckham SM, Tisdale B, Rodier PM (2000a) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22:319-324
62. Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM (2000b) Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology 62:393-405
63. Insel TR, O'Brien DJ, Leckman JF (1999) Oxytocin, vasopressin, and autism: is there a connection? Biol Psychiatry 45:145-157
64. Ito M (1998) Cerebellar learning in vestibulo-ocular reflex. Trends Cognit Sci 2:313-321
65. Jacobson JW, Ackerman LJ (1990) Differences in adaptive functioning among people with autism or mental retardation. J Autism Dev Disord 20:205-219
66. Jansen LMC (1998) Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res 33:87-94
67. Jansen LMC, Gispen-De Wied CC, Van Der Gaag RJ, Ten Hove F, Willemsenswinkels SWM, Harteveld E, Van Engeland H (2000) Unresponsiveness to psychosocial stress in a subgroup of autistic-like children, multiple complex developmental disorder. Psychoneuroendocrinology 25:753-764
68. Kahne D, Tudorica A, Borella A, Shapiro L, Johnstone F, Huang W, Whitaker-Azmitia PM (2002) Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 75:403-410
69. Kalat JM (1978). Speculations or similarities between autism and opiate addiction. J Autism Child Schizophr 8:477-479
70. Kanner L (1943) Austistic disturbances of affective contact. Nervous Child 32:217-253
71. Kilts CD (2001) The changing roles and targets for animal models of schizophrenia. Biol Psychiatry 50:845-855
72. Kleiman MD, Neff S, Rosman NP (1992) The brain in infantile autism: are posterior fossa structures abnormal? Neurology 42:753-760
73. Kline NS, Li CH, Lehmann HE, Lajtha A, Laski E, Cooper T (1977) Beta-endorphin-induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry 34:1111-1113
74. Konstantareas MM, Hewitt T (2001) Autistic disorder and schizophrenia: diagnostic overlaps. J Autism Dev Disord 31(1):19-28
75. Krause I, He XS, Gershwin ME, Shoenfeld Y (2002) Brief report: immune factors in autism: a critical review. J Autism Dev Disord 32:337-345
76. Krauss H, Marwinski K, Schulze T, Mueller DJ, Held T, Rietschel M, Maier W, Freyberger HJ (2000) Reliability and validity of the German version of the Premorbid Adjustment Scale (PAS). Nervenarzt 71(3):188-194
77. Kuehn MR, Bradley A, Robertson EJ, Evans MJ (1987) A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295-298
78. Larsen TK, Mouridsen SE (1997) The outcome in children with childhood autism and Asperger syndrome originally diagnosed as psychotic. A 30-year follow-up study of subjects assessed as children. Eur Child Adol Psychiatr 6:181-190
79. Lev-Ram V, Valsamis M, Masliah E, Levine S, Godfrey HP (1993) A novel non-ataxic guinea pigstrain with cerebrocortical and cerebellar abnormalities. Brain Res 606:325-331
80. Li J, Tabor HK, Nguyen L, Gleason C, Lotspeich LJ, Spiker D, Risch N, Myers RM (2002) Lack of association between HOXA1 and HOXB1 gene variants and autism in 110 multiplex families. Am J Med Genet 114:24-30
81. Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A (1997) Social interaction and sensorimotor gating abormalities in mice lacking Dvl1. Cell 90:895-905
82. Lindstrom LH, Besev G, Gunne LM, Terenius L (1986) CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites. Psychiatry Res 19:93-100
83. Lipska BK, Halim ND, Segal PN, Weinberg DR (2002) Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 22:2835-2842
84. Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23:223-239
85. Lipska BK, Weinberger DR (2002) A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox Res 4:469-475
86. Lubow RE (1973) Latent inhibition. Psychol Bull 79:398-407
87. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickard D (1998) A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3:328-332
88. Marcotte ER, Pearson DM, Srivastava LK (2001) Animal models of schizophrenia: a critical review. J Psychiatry Neurosci 26(5):395-410
89. McKinney WT (1977) Biobehavioral models of depression in monkeys. In: Usdin E, Hanin I (eds) Animal models in psychiatry and neurology. Pergamon Press, Oxford, pp 117-126
90. Modahl C, Green L, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H (1998) Plasma oxytocin levels in autistic children. Biol Psychiatry 43:270-277
91. Moser PC, Hitchcock JM, Lister S, Moran PM (2000) The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Rev 33:275-307
92. Mueser KT, Bellack AS, Douglas MS, Morrison RL (1991) Prevalence and stability of social skill deficits in schizophrenia. Schizophr Res 5:167-176
93. Murcia CL, Gulden F, Herrup K (2005) A question of balance: a proposal for new mouse models of autism. Int J Devl Neuroscience 23:265-275
94. Nielsen EB, Lyon M, Ellison G (1983) Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. J Nerv Ment Dis 171:222-233
95. Panksepp J (1979) A neurochemical theory of autism. Trends Neurosci 2:174-177
96. Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG (1980a) Endogenous opioids and social behavior. Neurol Biobehav Rev 4:473-487
97. Panksepp J, Meeker R, Bean NJ (1980b) The neurochemical control of crying. Pharmacol Biochem Behav 12:437-443
98. Panksepp J, Sahley TL (1987) Possible brain opioid involvement in disrupted social intent and language development of autism. In: Schopler E, Mesibov GB (eds) Neurobiological issues in autism. Plenum Press, New York, pp 357-372
99. Panksepp J, Siviy SM, Normansell LA (1985) Brain opioids and social emotions. In: Reite M, Field T (eds) The psychobiology of attachment and separation. Academic Press, New York, pp 3-49
100. Panksepp J, Vilberg T, Bean NJ, Coy DH, Kastin AJ (1978) Reduction of distress vocalization in chicks by opiate-like peptides. Brain Res Bull 3:663-667
101. Peters SL, Gray JA, Joseph MH (1991) Pre-weaning non-handling of rats disrupts latent inhibition in males, and results in persisting sex- and area-dependent increases in dopamine and serotonin turnover. Behav Pharmaco 12:215-223
102. Piven J, Nehme E, Simon J, Barta P, Pearlson G, Folstein S (1992) Magnetic resonance imaging in autism: measurement of the cerebellum, pons, and fourth ventricle. Biol Psychiatry 31:491-504
103. Pletnikov MV, Rubin SA, Moran TH, Carbone KM (2003) Exploring the cerebellum with a new tool: neonatal Borna disease virus (BDV) infection of the rat's brain. Cerebellum 2(1):62-70
104. Pletnikov MV, Rubin SA, Vasudevan K, Moran TH, Carbone KM (1999) Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav Brain Res 100:43-50
105. Poznanski EO (1976) Children's reactions to pain: a psychiatrist's perspective. Clin Pediatr 15:1114-1119
106. Rand MS (2004) Selection of animal models. Research animal methods. University of Arizona, Tucson
107. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower purkinje cell counts in the cerebellum of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143:862-866
108. Robbins TW, Sahakian BJ (1979) "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 18:931-950
109. Robins LN, Helzer JE (1986) Diagnostic and clinical assessment: the current state of psychiatric diagnosis. Ann Rev Psychol 37:409-432
110. Rodier PM, Ingram JL, Tisdale B, Croog VJ (1997) Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 11:417-422
111. Romano V, Cali F, Mirisola M, Gambino GRDA, Di Rosa P, Seidita G, Chiavetta V, Aiello F, Canziani F, De Leo G, Ayala GF, Elia M (2003) Lack of association of HOXA1 and HOXB1 mutations and autism in Sicilian (Italian) patients. Mol Psychiatry 8:716-717
112. Roubertoux PL, Guillot PV, Mortaud S, Pratte M, Jamon M, Cohen-Salmon C, Tordjman S (2005) Attack behaviors in mice: from factorial structure to quantitative trait loci mapping. Eur J Pharmacol 526(1-3):172-85
113. Roubertoux PL, Kerdelhué B (2006) Trisomy 21: from chromosomes to mental retardation. Behav Genet 36:344-468
114. Sahley TL, Panksepp J (1987) Brain opioids and autism: an updated analysis of possible linkages. J Autism Dev Disord 17:201-216
115. Salamone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21:341-359
116. Sandman CA (1992) Various endogenous opioids and autistic behavior: a response to Gillberg (letter to the editor). J Autism Dev Disord 22:132-133
117. Sandman CA, Barron JL, Chicz-Demet A, Demet EM (1991) Brief report: plasma β-endorphin and cortisol levels in autistic patients. J Autism Dev Disord 21:83-87
118. Sandman CA, McGivern RF, Berka C, Walker JM, Coy DH, Kastin AJ (1979) Neonatal administration of beta-endorphin produces «chronic» insensitivity to thermal stimuli. Life Sci 25:1755-1760
119. Schaefer GB, Thompson JN, Bodensteiner JB, McConnell JM, Kimberling WJ, Gay CT, Dutton WD, Hutchings DC, Gray SB (1996) Hypoplasia of the cerebellar vermis in neurogenetic syndromes. Ann Neurol 39:382-384
120. Schmajuk NA (1987). Animal models for schizophrenia: the hippocampally lesioned animal. Schizophr Bull 13:317-327
121. Shalev U, Feldon J, Weiner I (1998) Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: implications for a neurodevelopmental animal model of schizophrenia. Int J Dev Neurosci 16:279-288
122. Shalev U, Weiner I (2001) Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration. Behav Brain Res 126:57-63
123. Sher L (1997) Autistic disorder and the endogenous opioid system. Med Hypotheses 48:413-414
124. Singh MK, Giles LL, Nasrallah HA (2006) Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract 12(2):90-102
125. Solomon PR, Cride RA, Winkelman JW, Turi A, Kamer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 16:519-537
126. Soubrié P, Simon P (1989) Les modèles animaux en psychopharmacologie. Confrontations Psy: Les modèles expérimentaux et la clinique psychiatrique 30:113-129
127. Strömland K, Nordin V, Miller MT, Akerstrom B, Gillberg C (1994) Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36:351-356
128. Swerdlow NR, Braff DL, Geyer MA, Koob GF (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 21:23-33
129. Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414-420
130. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536
131. Szatmari P, Merette C, Bryson SE, Thivierge J, Roy MA, Cayer M, Maziade M (2002) Quantifying dimensions in autism: a factor-analytic study. J Am Acad Child Adolesc Psychiatry 4:467-474
132. Talebizadeh Z, Bittel DC, Miles JH, Takahashi N, Wang CH, Kibiryeva N, Butler MG (2002) No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). J Med Genet 39:70
133. Tantam D (1988) Asperger's syndrome. J Child Psychol Psychiatry 29:245-255
134. Tanguay PE (2000) Pervasive developmental disorders: a 10-year review. J Am Acad Child Adolesc Psychiatry 39:1079-1095
135. Thach WT (1998) What is the role of the cerebellum in motor learning and cognition? Trends Cognit Sci 2:331-337
136. Tordjman S, Anderson G, Macbride A, Hetzig M, Snow M, Hall L, Ferrari P, Cohen DJ (1997) Plasma B. endorphin, adrenocorticotropin hormone and cortisol in autism. J Child Psychol Psychiatry 38(6):705-716
137. Tordjman S, Antoine C, Cohen DJ, Gauvain-Piquard A, Carlier M, Roubertoux PL, Ferrari P. (1999). Etude des conduites autoagressives, de la réactivité à la douleur et de leurs interrelations chez les enfants autistes. L'Encéphale 25:122-134
138. Tordjman S, Carlier M, Cohen D, Cesselin F, Bourgoin S, Colas-Linhart N, Petiet A, Perez-Diaz F, Hamon M, Roubertoux PL (2003) Aggression and the three opioid families (Endorphins, Enkephalins and Dynorphins) in mice. Behav Genet 33:529-536
139. Tordjman S, Gutknecht L, Carlier M, Spitz E, Antoine C, Slama F, Carsalade V, Cohen DJ, Ferrari P, Roubertoux PL, Anderson GM (2001a) Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 6:434-439
140. Tordjman S, Mouchabac S, Botbol M (2001b) L'enfance des adolescents schizophrènes. Nervure 14:40-46
141. Torres AR (2003) Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr 3:9
142. Turner CA, Presti MF, Newman HA, Bugenhagen P, Crnic L, Lewis MH (2001) Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behav Genet 31(4):393-400
143. Van Den Bosch RJ, Van Asma MJ, Rombouts R, Louwerens JW (1992) Coping style and cognitive dysfunction in schizophrenic patients. Br J Psychiatry Suppl 18:123-128
144. Van Engeland H, Van Der Gaag RJ (1994) MCDD in childhood: a precursor of schizophrenic spectrum disorders. Schizophr Res 11:197
145. Van Gent T, Heijnen CJ, Treffers PDA (1997) Autism and the immune system. J. Child Psychol Psychiat 38:337-349
146. Van Wimersma A, Greidanus TJB, Van de Brug F, De Bruijckere LM, Pabst PHMA, Ruesink RW, Hulshof RLE, Van Berckel BNM, Arissen SM, De Koning EJP, Donker DK (1988) Comparison of bombesin, ACTH and beta-endorphin induced grooming: antagonism by haloperidol, naloxone and neurotensin. Ann NY Acad Sci 525:219-227
147. Volkmar FR, Cohen DJ (1991) Comorbid association of autism and schizophrenia. Am J Psychiatry 148(12):1705-1707
148. Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski E, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC (2001) Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 105:406-413
149. Watson S, Akil H, Berger P, et al (1979) Some observations on the opiate peptides and schizophrenia. Arch Gen Psychiatry 36:35-41
150. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
151. Weiner I (2003) The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169:257-297
152. Weiner I, Lubow RE, Feldon J (1984). Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83:194-199
153. Weiss J, Kilts CD (1994) Animal models of depression and schizophrenia. In: Schatzberg A, Nemeroff C (eds) Textbook of psychopharmacology. American Psychiatric Press, Washington, pp 81-123
154. Wiedl KH (1992) Assessment of coping with schizophrenia. Stressors, appraisals, and coping behaviour. Br J Psychiatry Suppl 18:114-122
155. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994) Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology 10(1):61-72
156. Willemsen-Swinkels SHN, Buitelaar JK, Nijhof GF, Van Engeland H (1995) Failure of Naltrexone to reduce self-injurious and autistic behavior in mentally retarded adults: double-blind placebo controlled studies. Arch Gen Psychiatry 52:766-773
157. World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, Geneve
158. Wu CL, Melton DW (1993) Production of a model for Lesch-Nyhan syndrome in hypoxanthine phophoribosyltransferase-deficient mice. Nat Genet 3:235-240
159. Yan WL, Guan XY, Green ED, Nicolson R, Yap TK, Zhang J, Jacobsen LK, Krasnewich DM, Kumra S, Lenane MC, Gochman P, Damschroder-Williams PJ, Esterling LE, Long RT, Martin BM, Sitransky E, Rapoport JL, Ginns EI (2000) Childhood-onset schizophrenia/autistic disorder and t (1;7) reciprocal translocation: identification of a BAC contig spanning the translocation breakpoint al 7q21. Am J Med Genet 96(6):749-753
160. Young LJ, Winslow JT, Wang Z, Gingrich B, Guo Q, Matzuk MM, Insel TR (1997) Gene targeting approaches to neuroendocrinology: oxytocin, maternal behavior, and affiliation. Horm Behav 31:221-231
161. Zarifian E (1989) La Clinique et les modèles neurochimiques. Confrontations Psy: Les modèles expérimentaux et la clinique psychiatrique 30:107-111